GeoVax Labs (GOVX) Non-cash Items (2010 - 2025)
GeoVax Labs (GOVX) posted quarterly Non-cash Items of -$543353.0 for Q4 2025, down 206.73% year-over-year from $509104.0 in Q4 2024, and down 608.76% quarter-over-quarter from $106799.0 in Q3 2025.
GeoVax Labs (GOVX) Non-cash Items (2010 - 2025) Analysis & Trends
GeoVax Labs (GOVX) has reported Non-cash Items for 16 consecutive years, with -$543353.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Non-cash Items fell 206.73% year-over-year to -$543353.0; the TTM figure through Dec 2025 stood at -$9198.0 (down 102.9% YoY), while the FY2025 annual figure was -$9198.0, down 102.9% from the prior year.
- Non-cash Items retreated to -$543353.0 in Q4 2025 per GOVX's latest filing, from $106799.0 in the prior quarter.
- Across five years, Non-cash Items topped out at $7.1 million in Q4 2021 and bottomed at -$3.5 million in Q3 2024.
- Historically, Non-cash Items has averaged $173276.2 across 5 years, with a median of $81146.5 in 2021.
- Annual changes were most pronounced in 2021 — Non-cash Items jumped 3536.64% — and 2022, when it tumbled 3171.69%.
- GeoVax Labs' Non-cash Items stood at $7.1 million in 2021, then slumped by 123.8% to -$1.7 million in 2022, then sank by 59.81% to -$2.7 million in 2023, then surged by 118.96% to $509104.0 in 2024, then plunged by 206.73% to -$543353.0 in 2025.
- Business Quant data shows GOVX's Non-cash Items at -$543353.0 in Q4 2025, $106799.0 in Q3 2025, and $1.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -543,353.00 |
| Dec 31, 2025 | -543,353.00 |
| Sep 30, 2025 | 106,799.00 |
| Sep 30, 2025 | 106,799.00 |
| Jun 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | -608,029.00 |
| Mar 31, 2025 | -608,029.00 |
| Dec 31, 2024 | 509,104.00 |
| Dec 31, 2024 | 509,104.00 |
| Sep 30, 2024 | -3.48 Mn |
| Sep 30, 2024 | -3.48 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Mar 31, 2024 | 166,402.00 |
| Mar 31, 2024 | 166,402.00 |
| Dec 31, 2023 | -2.69 Mn |
| Dec 31, 2023 | -2.69 Mn |
| Sep 30, 2023 | 3.31 Mn |
| Sep 30, 2023 | 3.31 Mn |